Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Русский
English
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
OSUR
#2938
OraSure Technologies Inc
3.1
5
+1.94%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+1.94%
Variazione Mensile
+16.24%
Variazione di 6 mesi
-5.69%
Variazione Annuale
-6.80%
Chiusura Precedente
3.0
9
Open
3.1
5
Bid
Ask
Low
3.1
5
High
3.1
5
Volume
50
Mercati
Mercato Azionario Statunitense
Salute
OSUR
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Total assets
464.08 M
479.66 M
457.61 M
445.04 M
423.1 M
Total liabilities
38.52 M
69.32 M
61.33 M
64.31 M
61.12 M
Total equity
425.56 M
410.34 M
396.28 M
380.72 M
361.98 M
Total liabilities & shareholders' equities
464.08 M
479.66 M
457.61 M
445.04 M
423.1 M
Total debt
—
—
—
—
—
Net debt
—
—
—
—
—
OraSure Technologies Inc
OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test.
Notizie
OraSure Technologies, Inc. (OSUR) Q4 2025 Earnings Call Transcript
OraSure: доходы совпали, прибыльa оказался ниже прогнозов в Q4
OraSure earnings matched, revenue fell short of estimates
OraSure’s HIV self-test receives Health Canada license
Phibro Animal Health (PAHC) Q2 Earnings and Revenues Surpass Estimates
Altai Capital выдвигает двух директоров в совет OraSure Technologies
Altai Capital nominates two directors for OraSure Technologies board
Altai Capital выдвигает двух директоров в совет OraSure
Altai Capital nominates two directors to OraSure board amid concerns
OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device
OraSure submits FDA applications for rapid STI test and collection device
Altai Capital выдвинет двух кандидатов в совет директоров OraSure